Galapagos NV
GLPG
#4563
Rank
โ‚ฌ1.81 B
Marketcap
27,13ย โ‚ฌ
Share price
-0.57%
Change (1 day)
6.21%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚ฌ7.56 Million

According to Galapagos NV's latest financial reports the company's total debt is โ‚ฌ7.56 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚ฌ11.72 M22.16%
2023-12-31โ‚ฌ9.59 M-56.18%
2022-12-31โ‚ฌ21.9 M-18.46%
2021-12-31โ‚ฌ26.85 M-8.75%
2020-12-31โ‚ฌ29.43 M15.96%
2019-12-31โ‚ฌ25.38 M
2018-12-31N/A-100%
2017-12-31โ‚ฌ0 M-85.71%
2016-12-31โ‚ฌ0.06 M-45.22%
2015-12-31โ‚ฌ0.11 M-31.14%
2014-12-31โ‚ฌ0.16 M-57.51%
2013-12-31โ‚ฌ0.39 M-2.96%
2012-12-31โ‚ฌ0.4 M-53.77%
2011-12-31โ‚ฌ0.87 M-29.64%
2010-12-31โ‚ฌ1.24 M-16.11%
2009-12-31โ‚ฌ1.48 M-11.98%
2008-12-31โ‚ฌ1.68 M-61.4%
2007-12-31โ‚ฌ4.36 M-43.76%
2006-12-31โ‚ฌ7.76 M-2.51%
2005-12-31โ‚ฌ7.96 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
โ‚ฌ28.02 B 370,540.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
โ‚ฌ39.33 B 520,047.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ21.92 B 289,889.02%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
โ‚ฌ59.04 B 780,695.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
โ‚ฌ59.45 M 686.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ11.11 B 146,886.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ14.66 B 193,818.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
โ‚ฌ20.49 B 270,928.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚ฌ35.53 B 469,833.20%๐Ÿ‡บ๐Ÿ‡ธ USA